Integral Ad Science Holding Corp. (NASDAQ:IAS) Short Interest Update

Integral Ad Science Holding Corp. (NASDAQ:IAS) was the recipient of a large decrease in short interest in September. As of September 15th, there was short interest totalling 5,560,000 shares, a decrease of 5.1% from the August 31st total of 5,860,000 shares. Currently, 7.7% of the shares of the stock are sold short. Based on an average daily trading volume, of 915,800 shares, the short-interest ratio is presently 6.1 days.

Integral Ad Science Stock Performance

Shares of NASDAQ IAS traded down $0.19 during trading hours on Monday, hitting $10.81. 657,121 shares of the company’s stock were exchanged, compared to its average volume of 1,468,700. The company’s 50-day moving average price is $10.99 and its 200-day moving average price is $10.11. Integral Ad Science has a 1-year low of $7.98 and a 1-year high of $17.53. The stock has a market capitalization of $1.74 billion, a price-to-earnings ratio of 1,100.00, a PEG ratio of 1.32 and a beta of 1.56. The company has a debt-to-equity ratio of 0.10, a current ratio of 3.76 and a quick ratio of 3.76.

Integral Ad Science (NASDAQ:IAS) last posted its quarterly earnings results on Thursday, August 1st. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.03. Integral Ad Science had a net margin of 0.57% and a return on equity of 0.31%. The company had revenue of $129.01 million for the quarter, compared to analyst estimates of $126.31 million. During the same period last year, the business posted $0.05 EPS. The business’s quarterly revenue was up 13.5% on a year-over-year basis. On average, sell-side analysts expect that Integral Ad Science will post 0.29 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Barclays raised their target price on Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Monday, August 5th. Morgan Stanley upped their target price on Integral Ad Science from $12.00 to $13.00 and gave the company an “equal weight” rating in a report on Tuesday, July 23rd. Benchmark restated a “hold” rating on shares of Integral Ad Science in a report on Monday, August 5th. Finally, Raymond James boosted their price objective on shares of Integral Ad Science from $13.00 to $15.00 and gave the company an “outperform” rating in a research report on Friday, August 2nd. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $16.40.

Insider Activity at Integral Ad Science

In related news, CEO Lisa Utzschneider sold 6,445 shares of the firm’s stock in a transaction that occurred on Monday, July 8th. The shares were sold at an average price of $9.68, for a total transaction of $62,387.60. Following the transaction, the chief executive officer now owns 214,563 shares in the company, valued at $2,076,969.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other Integral Ad Science news, CFO Tania Secor sold 6,643 shares of Integral Ad Science stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $11.24, for a total value of $74,667.32. Following the transaction, the chief financial officer now owns 251,366 shares in the company, valued at $2,825,353.84. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Lisa Utzschneider sold 6,445 shares of the stock in a transaction on Monday, July 8th. The shares were sold at an average price of $9.68, for a total value of $62,387.60. Following the sale, the chief executive officer now owns 214,563 shares of the company’s stock, valued at approximately $2,076,969.84. The disclosure for this sale can be found here. Insiders sold 27,636 shares of company stock worth $289,513 in the last 90 days. Corporate insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Integral Ad Science

A number of institutional investors have recently added to or reduced their stakes in the stock. Ameritas Investment Partners Inc. increased its position in shares of Integral Ad Science by 40.1% during the 1st quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock worth $67,000 after purchasing an additional 1,924 shares in the last quarter. XTX Topco Ltd acquired a new stake in shares of Integral Ad Science during the second quarter worth approximately $113,000. ProShare Advisors LLC bought a new position in shares of Integral Ad Science in the first quarter valued at approximately $121,000. Edgestream Partners L.P. acquired a new position in shares of Integral Ad Science in the 2nd quarter worth approximately $125,000. Finally, American Trust increased its holdings in Integral Ad Science by 18.0% during the 1st quarter. American Trust now owns 13,742 shares of the company’s stock valued at $137,000 after purchasing an additional 2,096 shares in the last quarter. 95.78% of the stock is owned by institutional investors and hedge funds.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.